After CMS and Novartis devised an outcomes-based payment approach for the new chimeric antigen receptor (CAR)-T treatment tisagenlecleucel (Kymriah), a group of representatives are requesting more ...
CMS has issued a final rule detailing how $4 billion in cuts to Medicaid Disproportionate Share Hospital payments will be implemented beginning Oct. 1. Under the Medicaid DSH program, hospitals that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results